Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

The tariff crash à la Trump is on! dynaCERT is causing a stir at the world's largest construction ma

Traffic in Munich is currently at a standstill for a week. With the start of the largest trade fair for construction machinery, building material machines, mining machines, construction vehicles, and construction equipment, “bauma” in Munich is takin...
André Will-Laudien | April 10, 2025 |

Iran, nuclear energy, oil – a revival for hydrogen! Nel ASA, Pure Hydrogen, Plug Power, and Oklo

The current attacks on Iran’s nuclear facilities by Israel mark a new level of escalation in the Middle East. Of course, a radical regime like Iran cannot be allowed to conduct nuclear research. This region has already experienced too much terror. For the ...
André Will-Laudien | June 16, 2025 |

Buzz on the Bullboards: One Step Closer to a Canadian-Made COVID Vaccine?

(Image via Theralase Technologies Inc.) Clinical-stage pharmaceutical company Theralase Technologies Inc. ( TSX-V: TLT , Forum ) has demonstrated proof-of-concept for its Canadian-made COVID-19 vaccine. In collaboration with the University of Manitoba (UM), t...
Stockhouse Editorial | February 9, 2022 |

Price-Leading Fuel Cell Technology with Zero CO2 Emissions

A fuel cell is a clean electrical power conversion/generation system, akin to a small power station that provides electricity and an equivalent amount of heat for various purposes. Alkaline Fuel Cell Power Corp. ( NEO.PWWR , Forum ) is at the forefront of this technolo...
Dave Jackson | September 24, 2021 |

Canadian Bitcoin portal stresses accessibility and independence

The Bitcoin world has experienced vast and rapid advancements, transforming from a niche digital currency into a mainstream financial asset. From its inception as a decentralized form of money, Bitcoin has evolved into a dynamic ecosystem, driving innovation in block...
Lyndsay Malchuk | July 9, 2024 |

Buzz on the Bullboards: Markets struggle in Q1 2023

Despite a solid start to the year, markets on Bay Street and Wall Street have struggled since fresh calendars went up. This week, Canada’s top banks have been pointing to economic pain ahead with higher loan loss provisions and a fall in quarterly prof...
Jonathon Brown | March 2, 2023 |

Almonty Industries – NASDAQ listing, Pentagon, world-class mine, critical raw materials: Ride the pe

Tungsten – hard, heat-resistant, indispensable for rockets, semiconductors, and high-tech tools. However, the global supply chain for this critical metal is on the verge of collapse. China’s export restrictions have choked the market, and Western stockpile...
Armin Schulz | June 12, 2025 |

Why Pan Orient Energy Is a Favorite

Pan Orient Energy Corp. (POE:TSX.V) is a simple story; it was clearly described in its Valentine's Day press release and the presentation on its website. Pan Orient has about ~70c CAD in cash per share and Thailand 2P reserve worth about ~70c CAD per share, and it...
Streetwise Reports | February 27, 2019 |

Aravive Shares Rise on Positive Patient Data from Phase 1b Ovarian Cancer Study

Shares of Aravive Inc. are trading higher after the firm posted positive data from the initial 12 patients enrolled in the Phase 1b portion of its study of AVB-500 used in the treatment of ovarian cancer. Today, in a late-breaking oral presentation at the European Soc...
Streetwise Reports | September 30, 2019 |

Zynex Shares Trade Higher After Reporting a 95% Increase in Q3 Orders

Non-invasive medical device maker Zynex Inc's. shares are trading 12% higher on an overall down market day after the company reported that Q3/19 orders are up 95% over the same period in 2018. This morning medical technology company specializing in manufacturing and s...
Streetwise Reports | October 3, 2019 |
1 2 3 4 5 6 7 8 9 10 ...